200 related articles for article (PubMed ID: 24958469)
1. Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.
Lee YH; Seo D; Choi KJ; Andersen JB; Won MA; Kitade M; Gómez-Quiroz LE; Judge AD; Marquardt JU; Raggi C; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
Cancer Res; 2014 Sep; 74(17):4752-61. PubMed ID: 24958469
[TBL] [Abstract][Full Text] [Related]
2. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)
Huang J; Yang G; Huang Y; Zhang S
Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma.
Ma F; Huang J; Li W; Li P; Liu M; Xue H
Environ Toxicol; 2022 Jul; 37(7):1675-1685. PubMed ID: 35286011
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1.
Yang Y; Zhang J; Wu T; Xu X; Cao G; Li H; Chen X
Life Sci; 2019 Jan; 216():200-206. PubMed ID: 30465789
[TBL] [Abstract][Full Text] [Related]
6. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
Lu D; Han C; Wu T
Oncogene; 2014 Feb; 33(9):1101-12. PubMed ID: 23542179
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
Jang YG; Hwang KA; Choi KC
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J
Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736
[TBL] [Abstract][Full Text] [Related]
9. Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53.
Di Leo L; Vegliante R; Ciccarone F; Salvatori I; Scimeca M; Bonanno E; Sagnotta A; Grazi GL; Aquilano K; Ciriolo MR
Oncogene; 2019 Mar; 38(11):1860-1875. PubMed ID: 30367149
[TBL] [Abstract][Full Text] [Related]
10. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
13. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
14. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
[TBL] [Abstract][Full Text] [Related]
15. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
16. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
17. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
18. SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.
Zhao M; Bu Y; Feng J; Zhang H; Chen Y; Yang G; Liu Z; Yuan H; Yuan Y; Liu L; Yun H; Wang J; Zhang X
Cancer Lett; 2020 Feb; 470():54-63. PubMed ID: 31790762
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.
Lu JW; Yang WY; Tsai SM; Lin YM; Chang PH; Chen JR; Wang HD; Wu JL; Jin SL; Yuh CH
PLoS One; 2013; 8(10):e76951. PubMed ID: 24130815
[TBL] [Abstract][Full Text] [Related]
20. Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins.
Noh JH; Jung KH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park WS; Lee JY; Nam SW
PLoS One; 2011; 6(11):e28103. PubMed ID: 22132221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
